Annual EBITDA
-$183.95 M
-$207.59 M-878.08%
31 December 2023
Summary:
Celularity annual earnings before interest, taxes, depreciation & amortization is currently -$183.95 million, with the most recent change of -$207.59 million (-878.08%) on 31 December 2023. During the last 3 years, it has risen by +$18.46 million (+9.12%). CELU annual EBITDA is now -878.08% below its all-time high of $23.64 million, reached on 31 December 2022.CELU EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$12.45 M
-$9.51 M-323.54%
01 September 2024
Summary:
Celularity quarterly earnings before interest, taxes, depreciation & amortization is currently -$12.45 million, with the most recent change of -$9.51 million (-323.54%) on 01 September 2024. Over the past year, it has increased by +$78.11 million (+86.25%). CELU quarterly EBITDA is now -123.44% below its all-time high of $53.13 million, reached on 30 September 2021.CELU Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$21.59 M
+$78.11 M+78.35%
01 September 2024
Summary:
Celularity TTM earnings before interest, taxes, depreciation & amortization is currently -$21.59 million, with the most recent change of +$78.11 million (+78.35%) on 01 September 2024. Over the past year, it has increased by +$147.99 million (+87.27%). CELU TTM EBITDA is now -151.33% below its all-time high of $42.05 million, reached on 30 June 2022.CELU TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CELU EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -878.1% | +86.3% | +87.3% |
| 3 y3 years | +9.1% | -123.4% | +73.4% |
| 5 y5 years | - | - | - |
CELU EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -878.1% | +9.1% | -123.4% | +86.3% | -151.3% | +88.3% |
| 5 y | 5 years | -878.1% | +9.1% | -123.4% | +86.3% | -151.3% | +88.3% |
| alltime | all time | -878.1% | +9.1% | -123.4% | +86.3% | -151.3% | +88.3% |
Celularity EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.45 M(+323.5%) | -$21.59 M(-78.3%) |
| June 2024 | - | -$2.94 M(-84.3%) | -$99.69 M(-29.4%) |
| Mar 2024 | - | -$18.71 M(-249.5%) | -$141.28 M(-23.2%) |
| Dec 2023 | -$183.95 M(-878.1%) | $12.52 M(-113.8%) | -$183.95 M(+8.5%) |
| Sept 2023 | - | -$90.56 M(+103.4%) | -$169.58 M(+136.1%) |
| June 2023 | - | -$44.52 M(-27.5%) | -$71.84 M(-414.4%) |
| Mar 2023 | - | -$61.38 M(-328.3%) | $22.85 M(-3.4%) |
| Dec 2022 | $23.64 M | $26.89 M(+274.7%) | $23.64 M(-706.2%) |
| Sept 2022 | - | $7.18 M(-85.7%) | -$3.90 M(-109.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $50.16 M(-182.8%) | $42.05 M(-160.2%) |
| Mar 2022 | - | -$60.58 M(+9149.3%) | -$69.84 M(-20.7%) |
| Dec 2021 | -$88.11 M(-56.5%) | -$655.00 K(-101.2%) | -$88.11 M(+8.7%) |
| Sept 2021 | - | $53.13 M(-186.1%) | -$81.06 M(-54.7%) |
| June 2021 | - | -$61.73 M(-21.7%) | -$179.00 M(+52.4%) |
| Mar 2021 | - | -$78.85 M(-1332.4%) | -$117.48 M(+204.1%) |
| Dec 2020 | -$202.41 M | $6.40 M(-114.3%) | -$38.63 M(-14.2%) |
| Sept 2020 | - | -$44.82 M(>+9900.0%) | -$45.03 M(>+9900.0%) |
| June 2020 | - | -$208.20 K | -$208.20 K |
FAQ
- What is Celularity annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Celularity?
- What is Celularity annual EBITDA year-on-year change?
- What is Celularity quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Celularity?
- What is Celularity quarterly EBITDA year-on-year change?
- What is Celularity TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Celularity?
- What is Celularity TTM EBITDA year-on-year change?
What is Celularity annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CELU is -$183.95 M
What is the all time high annual EBITDA for Celularity?
Celularity all-time high annual earnings before interest, taxes, depreciation & amortization is $23.64 M
What is Celularity annual EBITDA year-on-year change?
Over the past year, CELU annual earnings before interest, taxes, depreciation & amortization has changed by -$207.59 M (-878.08%)
What is Celularity quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CELU is -$12.45 M
What is the all time high quarterly EBITDA for Celularity?
Celularity all-time high quarterly earnings before interest, taxes, depreciation & amortization is $53.13 M
What is Celularity quarterly EBITDA year-on-year change?
Over the past year, CELU quarterly earnings before interest, taxes, depreciation & amortization has changed by +$78.11 M (+86.25%)
What is Celularity TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CELU is -$21.59 M
What is the all time high TTM EBITDA for Celularity?
Celularity all-time high TTM earnings before interest, taxes, depreciation & amortization is $42.05 M
What is Celularity TTM EBITDA year-on-year change?
Over the past year, CELU TTM earnings before interest, taxes, depreciation & amortization has changed by +$147.99 M (+87.27%)